Tioclomarol

Tioclomarol

SCHEMBL13724182

O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1.O=c1oc2ccccc2c(O)c1C(CC(O)c1ccc(Cl)cc1)c1ccc(Cl)s1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.47
NQO1 P15559 4/20 0.46
TOP2A P11388 1/20 0.43
CYP2C9 P11712 7/20 0.42
VKORC1 Q9BQB6 3/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41
TBXA2R P21731 1/20 0.41
PTGS1 P23219 1/20 0.41
ADRA1A P35348 1/20 0.41
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALB P02768 1/20 0.40
PCSK7 Q16549 1/20 0.40
CYP3A4 P08684 1/20 0.40
TOP1 P11387 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tioclomarol SCHEMBL43646 0.88 NQO1 (0.58) THRBNQO1TOP2ACYP2C9VKORC1
SCHEMBL1651856 0.76 THRB (0.42) THRBNQO1TOP2ACYP2C9VKORC1
Chlorophacinone SCHEMBL4187624 0.71 MEN1 (0.81) THRBMEN1KMT2AADORA3CHRM1
Chlorophacinone SCHEMBL29353036 0.71 MEN1 (0.81) THRBMEN1KMT2AADORA3CHRM1
Chlorophacinone SCHEMBL29455171 0.71 MEN1 (0.81) THRBMEN1KMT2AADORA3CHRM1
Chlorophacinone SCHEMBL11577573 0.71 MEN1 (0.81) THRBMEN1KMT2AADORA3CHRM1
Chlorophacinone SCHEMBL18961 0.71 MEN1 (0.81) THRBMEN1KMT2AADORA3CHRM1
Chlorophacinone SCHEMBL9356813 0.70 MEN1 (0.79) THRBMEN1KMT2AADORA3CHRM1
SCHEMBL1649084 0.67 NQO1 (0.70) NQO1TOP2ACYP2C9VKORC1MEN1
SCHEMBL7406235 0.66 CYP2C9 (0.82) NQO1CYP2C9VKORC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed
EP-2699572-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 EP disclosed
WO-2012143143-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed